Form 4: Scholar Rock R&D President Sells Shares to Cover Tax Obligations Under Pre-Arranged Plan
Insider Transaction Report
Akshay Vaishnaw, President of R&D and Director at Scholar Rock Holding Corp, sold 6,750 shares of common stock to satisfy tax withholding obligations related to RSU vesting, as part of a Rule 10b5-1 trading plan.
Summary
- Akshay Vaishnaw, President of R&D and a Director of Scholar Rock Holding Corp (SRRK), reported the sale of common stock.
- On May 29, 2025, Mr. Vaishnaw sold 5,130 shares of common stock at a weighted average price of $29.6297 per share, with prices ranging from $28.92 to $29.81.
- On the same date, he sold an additional 1,620 shares of common stock at a weighted average price of $30.0072 per share, with prices ranging from $29.92 to $30.19.
- The total number of shares sold across these two transactions was 6,750.
- These sales were executed pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025, specifically to cover tax withholding obligations arising from the vesting and settlement of Restricted Stock Units (RSUs).
- Following these transactions, Mr. Vaishnaw beneficially owns 616,205 shares, which consist of 16,205 shares of common stock, 100,000 RSUs, and 500,000 Performance Stock Units (PSUs), with PSUs representing the maximum number of shares that may be issued.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The transaction is a routine, pre-planned sale for tax purposes, which is a common occurrence for executives receiving equity compensation and does not typically signal a change in company outlook or management confidence.
Positives
- The sale was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and transparent transaction rather than a reactive one.
- The stated purpose of the sale was to cover tax withholding obligations upon RSU vesting, which is a common and routine reason for insider stock sales and does not necessarily reflect a negative outlook on the company.
Negatives
- The transaction resulted in a reduction of direct common stock ownership by a key executive, Akshay Vaishnaw, by 6,750 shares.
Risks
- While the sale was for tax purposes, any reduction in insider ownership, even if minor, could be perceived by some investors as a slight decrease in alignment between management and shareholder interests.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Management Comments
- "This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025 to cover tax withholding obligations upon the vesting and settlement of RSUs."
Industry Context
This filing is a routine insider transaction report specific to Scholar Rock Holding Corp and does not provide broader industry trends or competitive insights. Insider sales for tax purposes are common across all industries, including biotechnology, when executive compensation includes equity awards.
Stakeholder Impact
- Shareholders: A minor reduction in direct insider ownership, but generally viewed as a routine event given the tax-related purpose and 10b5-1 plan.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date Rule 10b5-1 trading plan was adopted. |
| 05/29/2025 | Date of stock transactions (sales). |
| 05/30/2025 | Date the Form 4 was signed by Attorney-in-Fact for Akshay Vaishnaw. |
Keywords
Scholar Rock Holding Corp, SRRK, Form 4, Insider Trading, Stock Sale, Akshay Vaishnaw, Rule 10b5-1, Tax Withholding, RSU Vesting, Executive Compensation, Biotechnology, Pharmaceuticals
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.